跳至主要内容
临床试验/NCT00893490
NCT00893490Unknown1 期

Ahmed Glaucoma Valve Alone,With Amniotic Membrane or With MMC for Treatment of Refractory Glaucoma

Shahid Beheshti University of Medical Sciences1 个研究点 分布在 1 个国家开始时间: 2009年5月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
试验地点
1

研究概览

简要总结

This randomized, controlled trial (RCT) compares the efficacy and safety of Ahmed Glaucoma Valve (AGV) implantation alone, with 3 minutes MMC application or with a single layer coverage of amniotic membrane. Outcomes include intraocular eye pressure (IOP), postoperative glaucoma medication and complications. AGV implantation site will be superior or inferior based on indication and these groups will be randomized separately.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
7 Years 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with refractory glaucoma

排除标准

  • children under 7 years old
  • adults above 75 years old
  • uncooperative patients
  • patients underwent the operation for second time
  • patients with major operation with AGV

研究组 & 干预措施

AGV plus MMC

Experimental

干预措施: Ahmed Glaucoma Valve (AGV) (Device)

AGV plus MMC

Experimental

干预措施: Mitomycin C (MMC) (Drug)

Ahmed Glaucoma Valve (AGV) alone

Experimental

干预措施: Ahmed Glaucoma Valve (AGV) (Device)

AGV plus amniotic membrane coverage

Experimental

干预措施: Ahmed Glaucoma Valve (AGV) (Device)

AGV plus amniotic membrane coverage

Experimental

干预措施: amniotic membrane coverage (Procedure)

研究者

研究点 (1)

Loading locations...

相似试验